Next Article in Journal
SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand
Next Article in Special Issue
Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
Previous Article in Journal
Predictors of COVID-19 Vaccine Intention: Evidence from Chile, Mexico, and Colombia
Previous Article in Special Issue
Forecasted Trends of the New COVID-19 Epidemic Due to the Omicron Variant in Thailand, 2022
 
 
Article

Article Versions Notes

Vaccines 2022, 10(7), 1130; https://doi.org/10.3390/vaccines10071130
Action Date Notes Link
article xml file uploaded 15 July 2022 11:30 CEST Original file -
article xml uploaded. 15 July 2022 11:30 CEST Update https://www.mdpi.com/2076-393X/10/7/1130/xml
article pdf uploaded. 15 July 2022 11:30 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1130/pdf
article supplementary file uploaded. 15 July 2022 11:30 CEST - https://www.mdpi.com/2076-393X/10/7/1130#supplementary
article html file updated 15 July 2022 11:32 CEST Original file -
article html file updated 13 August 2022 01:55 CEST Update https://www.mdpi.com/2076-393X/10/7/1130/html
Back to TopTop